Skip to main content
. 2021 Jul 16;100(28):e26537. doi: 10.1097/MD.0000000000026537

Table 2.

Values of NLR, PLR, and Hb/RDW in 180 patients with nasopharyngeal cancer.

Indicators N Hb/RDW P NLR P PLR P
Stage
I+II 84 989.87 ± 166.42 .152 2.67 ± 1.73 .043 147.53 ± 57.28 .424
III+IV 96 967.02 ± 171.00 3.27 ± 2.37 170.05 ± 98.92
Serosal invasion
T1+T2 56 1004.26 ± 142.69 .182 2.57 ± 1.68 .055 136.68 ± 50.03 .031
T3+T4 124 965.68 ± 178.58 3.18 ± 2.26 169.87 ± 92.15
Lymph node metastasis
Absence 84 985.20 ± 165.48 .301 2.66 ± 1.74 .030 146.80 ± 57.40 .313
Presence 96 971.11 ± 172.23 3.28 ± 2.36 170.69 ± 98.71
Distant metastasis
Absence 171 983.11 ± 166.97 .065 2.98 ± 2.13 .570 158.43 ± 79.29 .745
Presence 9 874.65 ± 180.30 3.25 ± 1.81 180.71 ± 137.72

P value was analyzed by the Kruskal–Wallis H test or the Wilcoxon rank-sum test.

Hb/RDW = hemoglobin-to-red cell distribution width ratio (Hb/RDW), NLR = neutrophil-to-lymphocyte ratio, PLR = platelet-to-lymphocyte ratio.